PP1/PP2A phosphatase inhibition-induced metaplasticity in protein synthesis blocker-treated hippocampal slices: LTP and LTD, or There and Back again

Biochem Biophys Res Commun. 2021 Jun 18:558:64-70. doi: 10.1016/j.bbrc.2021.04.061. Epub 2021 Apr 23.

Abstract

Long-term potentiation (LTP) and long-term depression (LTD) are key forms of synaptic plasticity in the hippocampus. LTP and LTD are believed to underlie the processes occurring during learning and memory. Search of mechanisms responsible for switching from LTP to LTD and vice versa is an important fundamental task. Protein synthesis blockers (PSB) are widely used in models of memory impairment and LTP suppression. Here, we found that blockade of serine/threonine phosphatases 1 (PP1) and 2A (PP2A) with the specific blockers, calyculin A (CalyA) or okadaic acid (OA), and simultaneous blockade of the protein translation by anisomycin or cycloheximide leads to a switch from PSB-impaired LTP to LTD. PP1/PP2A-dependent LTD was extremely sensitive to the intensity of the test stimuli, whose increase restored the field excitatory postsynaptic potentials (fEPSP) to the values corresponding to control LTP in the non-treated slices. PP1/PP2A blockade affected the basal synaptic transmission, increasing the paired-pulse facilitation (PPF) ratio, and restored the PSB-impaired PPF 3 h after tetanus. Prolonged exposure to anisomycin led to the NO synthesis increase (measured using fluorescent dye) both in the dendrites and somata of CA1, CA3, dentate gyrus (DG) hippocampal layers. OA partially prevented the NO production in the CA1 dendrites, as well in the CA3 and DG somas. Direct measurements of changes in serine/threonine phosphatase (STPP) activity revealed importance of the PP1/PP2A-dependent component in the late LTP phase (L-LTP) in anisomycin-treated slices. Thus, serine/threonine phosphatases PP1/PP2A influence both basal synaptic transmission and stimulation-induced synaptic plasticity.

Keywords: Anisomycin; Cycloheximide; Hippocampus; Synaptic plasticity; fEPSP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anisomycin / pharmacology
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / physiology
  • Cycloheximide / pharmacology
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / physiology*
  • In Vitro Techniques
  • Long-Term Potentiation / drug effects
  • Long-Term Potentiation / physiology
  • Long-Term Synaptic Depression / drug effects
  • Long-Term Synaptic Depression / physiology
  • Male
  • Marine Toxins / pharmacology
  • Neuronal Plasticity / drug effects*
  • Neuronal Plasticity / physiology*
  • Nitric Oxide / biosynthesis
  • Okadaic Acid / pharmacology
  • Oxazoles / pharmacology
  • Protein Phosphatase 1 / antagonists & inhibitors*
  • Protein Phosphatase 2 / antagonists & inhibitors*
  • Protein Synthesis Inhibitors / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Enzyme Inhibitors
  • Marine Toxins
  • Oxazoles
  • Protein Synthesis Inhibitors
  • Okadaic Acid
  • Nitric Oxide
  • Anisomycin
  • calyculin A
  • Cycloheximide
  • Protein Phosphatase 1
  • Protein Phosphatase 2